Form D · Other Technology
Sedare Biosciences, Inc.
Palo Alto, CA · CIK 0002008582
Offering snapshot reported Jan 23, 2024 · SEC filing
- Reported sold
- $2.5M Offering amount: $4.1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 10, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 23, 2024 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-503201
Source: Form D, filed Jan 23, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donald Mc Carthy | Director, Executive |
| David Parry | Director, Executive |
| Ravichandran Rao | Executive |
| Christian Richard | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
628 Middlefield Road
Palo Alto, CA, 94301
Palo Alto, CA, 94301